Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42016-01-1221PREAI
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutationsHAEMATOLOGICAIF7.92014-06-0387OAAI
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemiaLEUKEMIAIF13.42010-09-0227PREAI
Simultaneous proteosome inhibition and heat shock protein induction by bortezomib is beneficial in experimental pancreatitisEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72009-08-0111PREAI
HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for Chronic Myeloproliferative DiseaseCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42009-03-0912OAAI
Clinical characteristics of JAK2 V617F positive myeloproliferative diseasesBLOOD REVIEWSIF5.72007-08-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向